Report Detail

Medical Devices & Consumables Global Venous Thromboembolism (VTE) Devices Market Research Report 2021

  • RnM4295221
  • |
  • 22 March, 2021
  • |
  • Global
  • |
  • 120 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Venous Thromboembolism (VTE) Devices Market Overview

  • 1.1 Product Overview and Scope of Venous Thromboembolism (VTE) Devices
  • 1.2 Venous Thromboembolism (VTE) Devices Segment by Type
    • 1.2.1 Global Venous Thromboembolism (VTE) Devices Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Deep Vein Thrombosis(DVT)
    • 1.2.3 Pulmonary Embolism(PE)
    • 1.2.4 Others
  • 1.3 Venous Thromboembolism (VTE) Devices Segment by Application
    • 1.3.1 Venous Thromboembolism (VTE) Devices Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Surgical Centers
    • 1.3.4 Other
  • 1.4 Global Venous Thromboembolism (VTE) Devices Market Size Estimates and Forecasts
    • 1.4.1 Global Venous Thromboembolism (VTE) Devices Revenue 2016-2027
    • 1.4.2 Global Venous Thromboembolism (VTE) Devices Sales 2016-2027
    • 1.4.3 Venous Thromboembolism (VTE) Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Venous Thromboembolism (VTE) Devices Market Competition by Manufacturers

  • 2.1 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Venous Thromboembolism (VTE) Devices Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Venous Thromboembolism (VTE) Devices Manufacturing Sites, Area Served, Product Type
  • 2.5 Venous Thromboembolism (VTE) Devices Market Competitive Situation and Trends
    • 2.5.1 Venous Thromboembolism (VTE) Devices Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Venous Thromboembolism (VTE) Devices Players Market Share by Revenue
    • 2.5.3 Global Venous Thromboembolism (VTE) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Venous Thromboembolism (VTE) Devices Retrospective Market Scenario by Region

  • 3.1 Global Venous Thromboembolism (VTE) Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Venous Thromboembolism (VTE) Devices Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
    • 3.3.1 North America Venous Thromboembolism (VTE) Devices Sales by Country
    • 3.3.2 North America Venous Thromboembolism (VTE) Devices Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
    • 3.4.1 Europe Venous Thromboembolism (VTE) Devices Sales by Country
    • 3.4.2 Europe Venous Thromboembolism (VTE) Devices Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Venous Thromboembolism (VTE) Devices Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Venous Thromboembolism (VTE) Devices Sales by Region
    • 3.5.2 Asia Pacific Venous Thromboembolism (VTE) Devices Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
    • 3.6.1 Latin America Venous Thromboembolism (VTE) Devices Sales by Country
    • 3.6.2 Latin America Venous Thromboembolism (VTE) Devices Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Venous Thromboembolism (VTE) Devices Sales by Country
    • 3.7.2 Middle East and Africa Venous Thromboembolism (VTE) Devices Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Venous Thromboembolism (VTE) Devices Historic Market Analysis by Type

  • 4.1 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Type (2016-2021)
  • 4.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Type (2016-2021)
  • 4.3 Global Venous Thromboembolism (VTE) Devices Price by Type (2016-2021)

5 Global Venous Thromboembolism (VTE) Devices Historic Market Analysis by Application

  • 5.1 Global Venous Thromboembolism (VTE) Devices Sales Market Share by Application (2016-2021)
  • 5.2 Global Venous Thromboembolism (VTE) Devices Revenue Market Share by Application (2016-2021)
  • 5.3 Global Venous Thromboembolism (VTE) Devices Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 ArjoHuntleigh
    • 6.1.1 ArjoHuntleigh Corporation Information
    • 6.1.2 ArjoHuntleigh Description and Business Overview
    • 6.1.3 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 ArjoHuntleigh Product Portfolio
    • 6.1.5 ArjoHuntleigh Recent Developments/Updates
  • 6.2 Armetheon
    • 6.2.1 Armetheon Corporation Information
    • 6.2.2 Armetheon Description and Business Overview
    • 6.2.3 Armetheon Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Armetheon Product Portfolio
    • 6.2.5 Armetheon Recent Developments/Updates
  • 6.3 Bayer
    • 6.3.1 Bayer Corporation Information
    • 6.3.2 Bayer Description and Business Overview
    • 6.3.3 Bayer Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Bayer Product Portfolio
    • 6.3.5 Bayer Recent Developments/Updates
  • 6.4 Bio Compression Systems
    • 6.4.1 Bio Compression Systems Corporation Information
    • 6.4.2 Bio Compression Systems Description and Business Overview
    • 6.4.3 Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Bio Compression Systems Product Portfolio
    • 6.4.5 Bio Compression Systems Recent Developments/Updates
  • 6.5 Boehringer Ingelheim
    • 6.5.1 Boehringer Ingelheim Corporation Information
    • 6.5.2 Boehringer Ingelheim Description and Business Overview
    • 6.5.3 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Boehringer Ingelheim Product Portfolio
    • 6.5.5 Boehringer Ingelheim Recent Developments/Updates
  • 6.6 Breg
    • 6.6.1 Breg Corporation Information
    • 6.6.2 Breg Description and Business Overview
    • 6.6.3 Breg Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Breg Product Portfolio
    • 6.6.5 Breg Recent Developments/Updates
  • 6.7 Bristol-Myers Squibb
    • 6.6.1 Bristol-Myers Squibb Corporation Information
    • 6.6.2 Bristol-Myers Squibb Description and Business Overview
    • 6.6.3 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Bristol-Myers Squibb Product Portfolio
    • 6.7.5 Bristol-Myers Squibb Recent Developments/Updates
  • 6.8 Cardinal Health
    • 6.8.1 Cardinal Health Corporation Information
    • 6.8.2 Cardinal Health Description and Business Overview
    • 6.8.3 Cardinal Health Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Cardinal Health Product Portfolio
    • 6.8.5 Cardinal Health Recent Developments/Updates
  • 6.9 Currie Medical Specialties
    • 6.9.1 Currie Medical Specialties Corporation Information
    • 6.9.2 Currie Medical Specialties Description and Business Overview
    • 6.9.3 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Currie Medical Specialties Product Portfolio
    • 6.9.5 Currie Medical Specialties Recent Developments/Updates
  • 6.10 Daiichi-Sankyo
    • 6.10.1 Daiichi-Sankyo Corporation Information
    • 6.10.2 Daiichi-Sankyo Description and Business Overview
    • 6.10.3 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Daiichi-Sankyo Product Portfolio
    • 6.10.5 Daiichi-Sankyo Recent Developments/Updates
  • 6.11 Devon Medical Products
    • 6.11.1 Devon Medical Products Corporation Information
    • 6.11.2 Devon Medical Products Venous Thromboembolism (VTE) Devices Description and Business Overview
    • 6.11.3 Devon Medical Products Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Devon Medical Products Product Portfolio
    • 6.11.5 Devon Medical Products Recent Developments/Updates
  • 6.12 DJO
    • 6.12.1 DJO Corporation Information
    • 6.12.2 DJO Venous Thromboembolism (VTE) Devices Description and Business Overview
    • 6.12.3 DJO Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 DJO Product Portfolio
    • 6.12.5 DJO Recent Developments/Updates
  • 6.13 Janssen
    • 6.13.1 Janssen Corporation Information
    • 6.13.2 Janssen Venous Thromboembolism (VTE) Devices Description and Business Overview
    • 6.13.3 Janssen Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Janssen Product Portfolio
    • 6.13.5 Janssen Recent Developments/Updates
  • 6.14 Mego Afek AC LTD
    • 6.14.1 Mego Afek AC LTD Corporation Information
    • 6.14.2 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Description and Business Overview
    • 6.14.3 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Mego Afek AC LTD Product Portfolio
    • 6.14.5 Mego Afek AC LTD Recent Developments/Updates
  • 6.15 Normatec
    • 6.15.1 Normatec Corporation Information
    • 6.15.2 Normatec Venous Thromboembolism (VTE) Devices Description and Business Overview
    • 6.15.3 Normatec Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Normatec Product Portfolio
    • 6.15.5 Normatec Recent Developments/Updates
  • 6.16 Pfizer
    • 6.16.1 Pfizer Corporation Information
    • 6.16.2 Pfizer Venous Thromboembolism (VTE) Devices Description and Business Overview
    • 6.16.3 Pfizer Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Pfizer Product Portfolio
    • 6.16.5 Pfizer Recent Developments/Updates
  • 6.17 Portola Pharmaceuticals
    • 6.17.1 Portola Pharmaceuticals Corporation Information
    • 6.17.2 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Description and Business Overview
    • 6.17.3 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Portola Pharmaceuticals Product Portfolio
    • 6.17.5 Portola Pharmaceuticals Recent Developments/Updates
  • 6.18 ThermoTek USA
    • 6.18.1 ThermoTek USA Corporation Information
    • 6.18.2 ThermoTek USA Venous Thromboembolism (VTE) Devices Description and Business Overview
    • 6.18.3 ThermoTek USA Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 ThermoTek USA Product Portfolio
    • 6.18.5 ThermoTek USA Recent Developments/Updates
  • 6.19 Zimmer Biomet
    • 6.19.1 Zimmer Biomet Corporation Information
    • 6.19.2 Zimmer Biomet Venous Thromboembolism (VTE) Devices Description and Business Overview
    • 6.19.3 Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Zimmer Biomet Product Portfolio
    • 6.19.5 Zimmer Biomet Recent Developments/Updates

7 Venous Thromboembolism (VTE) Devices Manufacturing Cost Analysis

  • 7.1 Venous Thromboembolism (VTE) Devices Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Venous Thromboembolism (VTE) Devices
  • 7.4 Venous Thromboembolism (VTE) Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Venous Thromboembolism (VTE) Devices Distributors List
  • 8.3 Venous Thromboembolism (VTE) Devices Customers

9 Venous Thromboembolism (VTE) Devices Market Dynamics

  • 9.1 Venous Thromboembolism (VTE) Devices Industry Trends
  • 9.2 Venous Thromboembolism (VTE) Devices Growth Drivers
  • 9.3 Venous Thromboembolism (VTE) Devices Market Challenges
  • 9.4 Venous Thromboembolism (VTE) Devices Market Restraints

10 Global Market Forecast

  • 10.1 Venous Thromboembolism (VTE) Devices Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Venous Thromboembolism (VTE) Devices by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Venous Thromboembolism (VTE) Devices by Type (2022-2027)
  • 10.2 Venous Thromboembolism (VTE) Devices Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Venous Thromboembolism (VTE) Devices by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Venous Thromboembolism (VTE) Devices by Application (2022-2027)
  • 10.3 Venous Thromboembolism (VTE) Devices Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Venous Thromboembolism (VTE) Devices by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Venous Thromboembolism (VTE) Devices by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Deep Vein Thrombosis(DVT)
    Pulmonary Embolism(PE)
    Others

    Segment by Application
    Hospitals
    Surgical Centers
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    ArjoHuntleigh
    Armetheon
    Bayer
    Bio Compression Systems
    Boehringer Ingelheim
    Breg
    Bristol-Myers Squibb
    Cardinal Health
    Currie Medical Specialties
    Daiichi-Sankyo
    Devon Medical Products
    DJO
    Janssen
    Mego Afek AC LTD
    Normatec
    Pfizer
    Portola Pharmaceuticals
    ThermoTek USA
    Zimmer Biomet


    Summary:
    Get latest Market Research Reports on Venous Thromboembolism (VTE) Devices. Industry analysis & Market Report on Venous Thromboembolism (VTE) Devices is a syndicated market report, published as Global Venous Thromboembolism (VTE) Devices Market Research Report 2021. It is complete Research Study and Industry Analysis of Venous Thromboembolism (VTE) Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,097.28
    3,145.92
    4,194.56
    2,419.04
    3,628.56
    4,838.08
    315,609.90
    473,414.85
    631,219.80
    216,474.56
    324,711.84
    432,949.12
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report